Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR Wild-Type Lung Cancer: When There Is a Target, There Is a Targeted Drug

2015 ◽  
Vol 33 (5) ◽  
pp. 523-524 ◽  
Author(s):  
Fei Zhou ◽  
Xiaoxia Chen ◽  
Caicun Zhou
Sign in / Sign up

Export Citation Format

Share Document